ProfileGDS4718 / 1555749_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 11% 17% 6% 21% 15% 5% 15% 24% 20% 17% 14% 14% 10% 8% 11% 16% 14% 13% 13% 3% 32% 10% 17% 17% 13% 10% 19% 9% 11% 13% 14% 9% 14% 25% 10% 11% 9% 18% 20% 18% 18% 14% 9% 14% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8392911
GSM549102patient 115, normal, homogenized [OPG study]4.0557217
GSM549104patient 119, normal, homogenized [OPG study]3.591776
GSM549108patient 138, normal, homogenized [OPG study]4.2369221
GSM549119patient 077, normal, homogenized [OPG study]3.9519215
GSM549133patient 032, cancer, homogenized [OPG study]3.556535
GSM549139patient 042, cancer, homogenized [OPG study]3.9511515
GSM549099patient 107, normal, homogenized [OPG study]4.3133324
GSM549109patient 139, normal, homogenized [OPG study]4.1681620
GSM549110patient 046, normal, homogenized [OPG study]4.0267617
GSM549114patient 063, normal, homogenized [OPG study]3.9017714
GSM549122patient 082, normal, homogenized [OPG study]3.9234214
GSM549134patient 033, cancer, homogenized [OPG study]3.7902410
GSM549136patient 036, cancer, homogenized [OPG study]3.646188
GSM549140patient 044, cancer, homogenized [OPG study]3.7718611
GSM549111patient 047, normal, homogenized [OPG study]3.9747316
GSM549113patient 057, normal, homogenized [OPG study]3.8864214
GSM549132patient 031, cancer, homogenized [OPG study]3.890813
GSM549137patient 038, cancer, homogenized [OPG study]3.885613
GSM549142patient 047, cancer, homogenized [OPG study]3.533523
GSM549100patient 110, normal, homogenized [OPG study]4.626532
GSM549107patient 135, normal, homogenized [OPG study]3.7729710
GSM549115patient 068, normal, homogenized [OPG study]3.9830917
GSM549116patient 072, normal, homogenized [OPG study]4.0272517
GSM549120patient 078, normal, homogenized [OPG study]3.8908413
GSM549131patient 030, cancer, homogenized [OPG study]3.7331410
GSM549118patient 074, normal, homogenized [OPG study]4.1179419
GSM549129patient 027, cancer, homogenized [OPG study]3.761159
GSM549123patient 088, normal, homogenized [OPG study]3.8232211
GSM549124patient 006, cancer, homogenized [OPG study]3.9068613
GSM549126patient 015, cancer, homogenized [OPG study]3.9031614
GSM549128patient 025, cancer, homogenized [OPG study]3.737879
GSM549103patient 117, normal, homogenized [OPG study]3.9604714
GSM549117patient 073, normal, homogenized [OPG study]4.3161825
GSM549138patient 041, cancer, homogenized [OPG study]3.7549610
GSM549141patient 045, cancer, homogenized [OPG study]3.762911
GSM549130patient 028, cancer, homogenized [OPG study]3.754969
GSM549101patient 111, normal, homogenized [OPG study]4.0770918
GSM549105patient 128, normal, homogenized [OPG study]4.1737120
GSM549106patient 134, normal, homogenized [OPG study]4.0301718
GSM549112patient 048, normal, homogenized [OPG study]4.0866718
GSM549125patient 011, cancer, homogenized [OPG study]3.9413414
GSM549127patient 024, cancer, homogenized [OPG study]3.730319
GSM549135patient 035, cancer, homogenized [OPG study]3.8699314